Endocrine treatment options for advanced breast cancer – the role of fulvestrant

This publication has 37 references indexed in Scilit:

• Fulvestrant versus anastrozole for the treatment of advanced breast carcinoma in postmenopausal women
  Cancer, 2003
• Anastrozole alone or in combination with tamoxifen versus tamoxifen alone for adjuvant treatment of postmenopausal women with early breast cancer: first results of the ATAC randomised trial
  The Lancet, 2002
• The MORE Trial: Multiple Outcomes for Raloxifene Evaluation
  Annals of the New York Academy of Sciences, 2001
• Back to Basics: Administering IM Injections the Right Way
  The American Journal of Nursing, 1996
• Responses to Pure Antiestrogens (ICI 164384, ICI182780) in Estrogen‐Sensitive and‐Resistant Experimental and Clinical Breast Cancera
  Annals of the New York Academy of Sciences, 1995
• Endometrial Cancer in Tamoxifen-Treated Breast Cancer Patients: Findings From the National Surgical Adjuvant Breast and Bowel Project (NSABP) B-14 *
  JNCI Journal of the National Cancer Institute, 1994
• High dose toremifene in advanced breast cancer resistant to or relapsed during tamoxifen treatment
  Breast Cancer Research and Treatment, 1994
• Circumvention of tamoxifen resistance by the pure anti‐estrogen ICI 182, 780
  International Journal of Cancer, 1993
• Adjuvant tamoxifen in primary breast cancer: Influence on plasma lipids and antithrombin III levels
  Breast Cancer Research and Treatment, 1988
• Phase II Evaluation of Lyl56758 in Metastatic Breast Cancer
  Oncology, 1988